113 related articles for article (PubMed ID: 26703821)
1. Atypical Phacomatosis Pigmentokeratotica as the Expression of a Mosaic RASopathy With the BRAF-Glu586Lys Mutation.
Ayala D; Ramón MD; Martín JM; Jordá E
Actas Dermosifiliogr; 2016 May; 107(4):344-6. PubMed ID: 26703821
[No Abstract] [Full Text] [Related]
2. Phacomatosis pigmentokeratotica is caused by a postzygotic HRAS mutation in a multipotent progenitor cell.
Groesser L; Herschberger E; Sagrera A; Shwayder T; Flux K; Ehmann L; Wollenberg A; Torrelo A; Bagazgoitia L; Diaz-Ley B; Tinschert S; Oschlies I; Singer S; Mickler M; Toll A; Landthaler M; Real FX; Hafner C
J Invest Dermatol; 2013 Aug; 133(8):1998-2003. PubMed ID: 23337891
[TBL] [Abstract][Full Text] [Related]
3. Postzygotic BRAF p.Lys601Asn Mutation in Phacomatosis Pigmentokeratotica with Woolly Hair Nevus and Focal Cortical Dysplasia.
Kuentz P; Mignot C; St-Onge J; Duffourd Y; Bonniaud B; Faivre L; Rivière JB; Vabres P
J Invest Dermatol; 2016 May; 136(5):1060-1062. PubMed ID: 26829038
[No Abstract] [Full Text] [Related]
4. Phacomatosis Pigmentokeratotica: A Mosaic RASopathy with Malignant Potential.
Om A; Cathey SS; Gathings RM; Hudspeth M; Lee JA; Marzolf S; Wine Lee L
Pediatr Dermatol; 2017 May; 34(3):352-355. PubMed ID: 28523882
[TBL] [Abstract][Full Text] [Related]
5. Phacomatosis pigmentokeratotica and precocious puberty associated with HRAS mutation.
Martin RJ; Arefi M; Splitt M; Redford L; Moss C; Rajan N
Br J Dermatol; 2018 Jan; 178(1):289-291. PubMed ID: 28489335
[No Abstract] [Full Text] [Related]
6. Lack of association between BRAF mutation and MAPK ERK activation in melanocytic nevi.
Uribe P; Andrade L; Gonzalez S
J Invest Dermatol; 2006 Jan; 126(1):161-6. PubMed ID: 16417232
[TBL] [Abstract][Full Text] [Related]
7. The absence of BRAF, FGFR3, and PIK3CA mutations differentiates lentigo simplex from melanocytic nevus and solar lentigo.
Hafner C; Stoehr R; van Oers JM; Zwarthoff EC; Hofstaedter F; Klein C; Landthaler M; Hartmann A; Vogt T
J Invest Dermatol; 2009 Nov; 129(11):2730-5. PubMed ID: 19536147
[No Abstract] [Full Text] [Related]
8. HRAS mutation in phacomatosis pigmentokeratotica without extracutaneous disease.
Jennings L; Cummins R; Murphy GM; Gulmann C; O'Kane M
Clin Exp Dermatol; 2017 Oct; 42(7):791-792. PubMed ID: 28736904
[No Abstract] [Full Text] [Related]
9. Variant of phacomatosis pigmentokeratotica.
Park HY; Kim JH; Ji JH; Ahn SK; Hong SP
J Dermatol; 2011 Jul; 38(7):719-22. PubMed ID: 21352309
[No Abstract] [Full Text] [Related]
10. Melanocytic nevi excised during B-Raf proto-oncogene (BRAF) inhibitor therapy: A study of 19 lesions from 10 patients.
Mochel MC; Hammond MR; Frederick DT; Alora-Palli MB; Piris A; Flaherty KT; Hoang MP
J Am Acad Dermatol; 2015 Sep; 73(3):491-9.e2. PubMed ID: 26190239
[TBL] [Abstract][Full Text] [Related]
11. Phacomatosis pigmentokeratotica is a "pseudodidymosis".
Happle R
J Invest Dermatol; 2013 Aug; 133(8):1923-5. PubMed ID: 23856930
[TBL] [Abstract][Full Text] [Related]
12. The first case of Chinese phacomatosis pigmentokeratotica diagnosed by a missense HRAS mosaicism.
Huang L; Zhang J; Chen F; Zhang X; Cao Y; Cheng R; Deng D
J Dermatol; 2022 Sep; 49(9):921-924. PubMed ID: 35567308
[TBL] [Abstract][Full Text] [Related]
13. Gene Mutation Mapping in a Fatal Case of Phacomatosis Pigmentokeratotica Happle.
Hayani K; Giehl K; Kumbrink J; Fischer J; Schlaak M; French LE; Wollenberg A
Acta Derm Venereol; 2020 Aug; 100(15):adv00241. PubMed ID: 32725253
[TBL] [Abstract][Full Text] [Related]
14. B-RAF and melanocytic neoplasia.
Gill M; Celebi JT
J Am Acad Dermatol; 2005 Jul; 53(1):108-14. PubMed ID: 15965430
[TBL] [Abstract][Full Text] [Related]
15. Papular nevus spilus syndrome: old and new aspects of a mosaic RASopathy.
Torchia D; Happle R
Eur J Dermatol; 2019 Feb; 29(1):2-5. PubMed ID: 30827948
[TBL] [Abstract][Full Text] [Related]
16. Phacomatosis pigmentokeratotica: a case of HRAS mosaicism causing rhabdomyosarcoma.
Prieto-Barrios M; Llamas-Martin R; Velasco-Tamariz V; Calleja-Algarra A; Ruano Y; Ortiz-Romero PL; Rodriguez-Peralto JL
Br J Dermatol; 2018 Nov; 179(5):1163-1167. PubMed ID: 29430633
[TBL] [Abstract][Full Text] [Related]
17. Phacomatosis pigmentokeratotica: A very rare twin spotting phenomenon.
Karia DR; Solanki AN; Jagati AG; Shah BJ
Indian J Dermatol Venereol Leprol; 2018; 84(1):120. PubMed ID: 28799528
[No Abstract] [Full Text] [Related]
18. Predictors of BRAF mutation in melanocytic nevi: analysis across regions with different UV radiation exposure.
Karram S; Novy M; Saroufim M; Loya A; Taraif S; Houreih MA; Rauscher B; Habib RH; Oberkanins C; Khalifeh I
Am J Dermatopathol; 2013 Jun; 35(4):412-8. PubMed ID: 23051629
[TBL] [Abstract][Full Text] [Related]
19. BRAF and NRAS mutations in melanoma and melanocytic nevi.
Poynter JN; Elder JT; Fullen DR; Nair RP; Soengas MS; Johnson TM; Redman B; Thomas NE; Gruber SB
Melanoma Res; 2006 Aug; 16(4):267-73. PubMed ID: 16845322
[TBL] [Abstract][Full Text] [Related]
20. Giant congenital melanocytic naevus with a novel CUX1-BRAF fusion mutation treated with trametinib.
Molho-Pessach V; Hartshtark S; Merims S; Lotem M; Caplan N; Alfassi H; Maly A; Goldstein G; Muskatel RS
Br J Dermatol; 2022 Dec; 187(6):1052-1054. PubMed ID: 36030465
[No Abstract] [Full Text] [Related]
[Next] [New Search]
